Analysts Set Trupanion, Inc. (NASDAQ:TRUP) PT at $39.20

Trupanion, Inc. (NASDAQ:TRUP) has received an average recommendation of “Hold” from the six brokerages that are presently covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average 1 year price target among brokers that have covered the stock in the last year is $39.20.

A number of analysts have issued reports on the stock. Stifel Nicolaus boosted their price objective on shares of Trupanion from $28.00 to $29.00 and gave the company a “hold” rating in a report on Thursday, August 20th. Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Monday, August 24th. Weiss Ratings upgraded Trupanion from a “hold (c-)” rating to a “hold (c)” rating in a research note on Wednesday, August 26th. Piper Sandler downgraded Trupanion from an “overweight” rating to a “neutral” rating and reduced their price target for the stock from $45.00 to $32.00 in a research report on Wednesday, August 26th. Finally, Atlantic Securities set a $42.00 price objective on Trupanion in a research note on Wednesday, July 15th.

Insiders Place Their Bets

In related news, CFO Fawwad Qureshi sold 6,111 shares of the stock in a transaction that occurred on Wednesday, August 26th. The shares were sold at an average price of $30.01, for a total value of $183,391.11. Following the completion of the transaction, the chief financial officer owned 4,230 shares of the company’s stock, valued at $126,942.30. This represents a 59.09% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CEO Margaret Tooth sold 978 shares of the firm’s stock in a transaction that occurred on Tuesday, August 11th. The shares were sold at an average price of $29.05, for a total transaction of $28,410.90. Following the completion of the sale, the chief executive officer owned 175,401 shares in the company, valued at $5,095,399.05. This represents a 0.55% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 12,046 shares of company stock worth $356,210 over the last three months. Insiders own 5.58% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors have recently modified their holdings of the stock. Bank of New York Mellon Corp acquired a new stake in shares of Trupanion during the second quarter valued at about $4,631,000. Renaissancere Holdings Ltd. acquired a new position in shares of Trupanion in the second quarter valued at approximately $6,514,510. GSA Capital Partners LLP acquired a new position in shares of Trupanion in the second quarter valued at approximately $1,394,000. Legal & General Group Plc bought a new position in Trupanion in the 2nd quarter valued at approximately $1,938,000. Finally, Renaissance Technologies LLC raised its holdings in Trupanion by 550.0% in the 1st quarter. Renaissance Technologies LLC now owns 39,000 shares of the financial services provider’s stock valued at $999,000 after buying an additional 33,000 shares during the last quarter.

Trupanion Stock Up 0.8%

TRUP stock opened at $25.00 on Friday. Trupanion has a fifty-two week low of $21.16 and a fifty-two week high of $46.98. The company has a debt-to-equity ratio of 0.24, a current ratio of 1.77 and a quick ratio of 1.77. The stock has a market capitalization of $1.10 billion, a price-to-earnings ratio of 47.17, a PEG ratio of 1.68 and a beta of 1.45. The business’s fifty day moving average price is $27.45 and its two-hundred day moving average price is $25.78.

Trupanion (NASDAQ:TRUP) last announced its earnings results on Wednesday, August 5th. The financial services provider reported $0.16 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.11 by $0.05. Trupanion had a net margin of 1.53% and a return on equity of 5.96%. The company had revenue of $392.93 million during the quarter, compared to analysts’ expectations of $389.72 million. During the same quarter in the previous year, the business posted $0.22 earnings per share. Trupanion’s quarterly revenue was up 11.1% on a year-over-year basis. On average, equities analysts anticipate that Trupanion will post 0.63 earnings per share for the current year.

Trupanion Company Profile

Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.

Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.